LON:PXSProvexis Share Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Provexis plc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add GBX 0.80 +0.01 (+1.26 %) (As of 07/10/2020 04:00 PM ET) Add Compare Share Today's Range 0.76Now: GBX 0.81▼ 0.7750-Day Range 0.75MA: GBX 0.84▼ 1.0352-Week Range 0.25Now: GBX 0.81▼ 1.08Volume192,022 shsAverage Volume688,515 shsMarket Capitalization£16.58 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartCompetitorsHeadlines Provexis plc, together with its subsidiaries, develops, licenses, and markets functional foods, medical foods, and dietary supplements worldwide. Its products include Fruitflow, a tomato extract that reduces the propensity for aberrant blood clotting typically associated with cardiovascular diseases, such as heart attack and stroke. The company's syrup and powder versions of Fruitflow are used in foods, beverages, and dietary supplement formats. It also offers Fruitflow + Omega-3, a supplement in capsule form that supports healthy blood flow and normal heart function. The company offers its products through retail stores, as well as online. Provexis plc was founded in 1999 and is based in Reading, the United Kingdom.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Provexis. Previous Next 2.3 Community Rank Outperform VotesProvexis has received 61 “outperform” votes. (Add your “outperform” vote.)Underperform VotesProvexis has received 69 “underperform” votes. (Add your “underperform” vote.)Community SentimentProvexis has received 53.08% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Provexis and other stocks. Vote “Outperform” if you believe PXS will outperform the S&P 500 over the long term. Vote “Underperform” if you believe PXS will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldProvexis does not currently pay a dividend.Dividend GrowthProvexis does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Provexis insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.46 out of 5 stars Industry, Sector and Symbol Stock Exchange LON Industry Personal Products Sub-IndustryN/A SectorConsumer Goods Current SymbolLON:PXS Previous Symbol CUSIPN/A CIKN/A Webwww.provexis.org Phone+44-1753-861777Debt Debt-to-Equity RatioN/A Current Ratio2.34 Quick Ratio2.18Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales£350,698.00 Price / Sales47.27 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees4 Outstanding Shares2,059,320,064Market Cap£16.58 million Next Earnings DateN/A OptionableNot Optionable LSE:PXS Rates by TradingView Receive PXS News and Ratings via Email Sign-up to receive the latest news and ratings for PXS and its competitors with MarketBeat's FREE daily newsletter. Provexis (LON:PXS) Frequently Asked Questions How has Provexis' stock been impacted by COVID-19 (Coronavirus)? Provexis' stock was trading at GBX 0.52 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, PXS shares have increased by 56.3% and is now trading at GBX 0.81. View which stocks have been most impacted by Coronavirus. Has Provexis been receiving favorable news coverage? News coverage about PXS stock has been trending negative recently, InfoTrie Sentiment reports. The research group identifies positive and negative news coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Provexis earned a coverage optimism score of -2.4 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the company's share price in the near future. View the latest news about Provexis. Who are some of Provexis' key competitors? Some companies that are related to Provexis include Creightons (CRL), Swallowfield (SWL), Byotrol (BYOT), CCA Industries (CAW), Scott's Liquid Gold (SLGD) and Unibail Rodamco (UL). View all competitors. What other stocks do shareholders of Provexis own? Based on aggregate information from My MarketBeat watchlists, some companies that other Provexis investors own include Taylor Wimpey (TW), ValiRx (VAL), Sirius Minerals (SXX), Lloyds Banking Group (LLOY) and easyJet (EZJ). Who are Provexis' key executives? Provexis' management team includes the following people: Mr. Ian Ford, CFO, COO, Company Sec. & Director (Age 53)Dr. Niamh Ann O'Kennedy BSc, MSc, Ph.D., Chief Scientific Officer, Member of Scientific Advisory Board & Director (Age 45)Prof. Asim K. Duttaroy BS MS Ph.D., DSc FICN, Consultant & Member of Scientific Advisory Board What is Provexis' stock symbol? Provexis trades on the London Stock Exchange (LON) under the ticker symbol "PXS." How do I buy shares of Provexis? Shares of PXS and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What is Provexis' stock price today? One share of PXS stock can currently be purchased for approximately GBX 0.81. How big of a company is Provexis? Provexis has a market capitalization of £16.58 million and generates £350,698.00 in revenue each year. Provexis employs 4 workers across the globe. What is Provexis' official website? The official website for Provexis is www.provexis.org. How can I contact Provexis? Provexis' mailing address is Prospect HSE, 58 Queens Road, READING, RG1 4RP, United Kingdom. The company can be reached via phone at +44-1753-861777. This page was last updated on 7/10/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
